A detailed history of Taurus Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Taurus Asset Management, LLC holds 2,562 shares of LLY stock, worth $2.07 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
2,562
Previous 2,640 2.95%
Holding current value
$2.07 Million
Previous $2.05 Million 12.96%
% of portfolio
0.25%
Previous 0.22%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$724.87 - $909.04 $56,539 - $70,905
-78 Reduced 2.95%
2,562 $2.32 Million
Q1 2023

May 08, 2023

SELL
$310.63 - $364.82 $16,774 - $19,700
-54 Reduced 2.0%
2,640 $906,000
Q4 2022

Feb 10, 2023

SELL
$321.55 - $374.67 $8,360 - $9,741
-26 Reduced 0.96%
2,694 $985,000
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $63,704 - $74,359
-575 Reduced 17.45%
2,720 $301,000
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $269,992 - $289,597
3,295
3,295 $278,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $766B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Taurus Asset Management, LLC Portfolio

Follow Taurus Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Taurus Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Taurus Asset Management, LLC with notifications on news.